Literature DB >> 27226600

Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.

Li-Hua Zhao1, Yanting Yin2, Dehua Yang3, Bo Liu4, Li Hou4, Xiaoxi Wang4, Kuntal Pal5, Yi Jiang4, Yang Feng3, Xiaoqing Cai3, Antao Dai3, Mingyao Liu6, Ming-Wei Wang7, Karsten Melcher8, H Eric Xu9.   

Abstract

G protein-coupled receptors (GPCRs) from the secretin-like (class B) family are key players in hormonal homeostasis and are important drug targets for the treatment of metabolic disorders and neuronal diseases. They consist of a large N-terminal extracellular domain (ECD) and a transmembrane domain (TMD) with the GPCR signature of seven transmembrane helices. Class B GPCRs are activated by peptide hormones with their C termini bound to the receptor ECD and their N termini bound to the TMD. It is thought that the ECD functions as an affinity trap to bind and localize the hormone to the receptor. This in turn would allow the hormone N terminus to insert into the TMD and induce conformational changes of the TMD to activate downstream signaling. In contrast to this prevailing model, we demonstrate that human class B GPCRs vary widely in their requirement of the ECD for activation. In one group, represented by corticotrophin-releasing factor receptor 1 (CRF1R), parathyroid hormone receptor (PTH1R), and pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1R), the ECD requirement for high affinity hormone binding can be bypassed by induced proximity and mass action effects, whereas in the other group, represented by glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R), the ECD is required for signaling even when the hormone is covalently linked to the TMD. Furthermore, the activation of GLP-1R by small molecules that interact with the intracellular side of the receptor is dependent on the presence of its ECD, suggesting a direct role of the ECD in GLP-1R activation.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein; G protein-coupled receptor (GPCR); glucagon; parathyroid hormone; peptide hormone

Mesh:

Substances:

Year:  2016        PMID: 27226600      PMCID: PMC4946928          DOI: 10.1074/jbc.M116.726620

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Passing the baton in class B GPCRs: peptide hormone activation via helix induction?

Authors:  Christoph Parthier; Steffen Reedtz-Runge; Rainer Rudolph; Milton T Stubbs
Journal:  Trends Biochem Sci       Date:  2009-05-14       Impact factor: 13.807

2.  Membrane-tethered ligands are effective probes for exploring class B1 G protein-coupled receptor function.

Authors:  Jean-Philippe Fortin; Yuantee Zhu; Charles Choi; Martin Beinborn; Michael N Nitabach; Alan S Kopin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-23       Impact factor: 11.205

3.  Molecular basis for negative regulation of the glucagon receptor.

Authors:  Christopher M Koth; Jeremy M Murray; Susmith Mukund; Azadeh Madjidi; Alexandra Minn; Holly J Clarke; Terence Wong; Vicki Chiang; Elizabeth Luis; Alberto Estevez; Jesus Rondon; Yingnan Zhang; Isidro Hötzel; Bernard B Allan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

4.  Small-molecule agonists for the glucagon-like peptide 1 receptor.

Authors:  Lotte Bjerre Knudsen; Dan Kiel; Min Teng; Carsten Behrens; Dilip Bhumralkar; János T Kodra; Jens J Holst; Claus B Jeppesen; Michael D Johnson; Johannes Cornelis de Jong; Anker Steen Jorgensen; Tim Kercher; Jarek Kostrowicki; Peter Madsen; Preben H Olesen; Jacob S Petersen; Fritz Poulsen; Ulla G Sidelmann; Jeppe Sturis; Larry Truesdale; John May; Jesper Lau
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

5.  A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.

Authors:  Desu Chen; Jiayu Liao; Na Li; Caihong Zhou; Qing Liu; Guangxing Wang; Rui Zhang; Song Zhang; Lilin Lin; Kaixian Chen; Xin Xie; Fajun Nan; Andrew A Young; Ming-Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

6.  Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Celine Valant; Rohan Sridhar; Owen L Woodman; Laurence J Miller; Roger J Summers; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2010-06-14       Impact factor: 4.436

7.  Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands.

Authors:  Denise Wootten; Emilia E Savage; Francis S Willard; Ana B Bueno; Kyle W Sloop; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2013-01-24       Impact factor: 4.436

8.  Structure of the human glucagon class B G-protein-coupled receptor.

Authors:  Fai Yiu Siu; Min He; Chris de Graaf; Gye Won Han; Dehua Yang; Zhiyun Zhang; Caihong Zhou; Qingping Xu; Daniel Wacker; Jeremiah S Joseph; Wei Liu; Jesper Lau; Vadim Cherezov; Vsevolod Katritch; Ming-Wei Wang; Raymond C Stevens
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

9.  Allosteric modulation of endogenous metabolites as an avenue for drug discovery.

Authors:  Denise Wootten; Emilia E Savage; Celine Valant; Lauren T May; Kyle W Sloop; James Ficorilli; Aaron D Showalter; Francis S Willard; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2012-05-10       Impact factor: 4.436

10.  Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.

Authors:  Kyle W Sloop; Francis S Willard; Martin B Brenner; James Ficorilli; Kathleen Valasek; Aaron D Showalter; Thomas B Farb; Julia X C Cao; Amy L Cox; M Dodson Michael; Sonia Maria Gutierrez Sanfeliciano; Mark J Tebbe; Michael J Coghlan
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

View more
  21 in total

1.  Impact of Substitution Registry on the Receptor-Activation Profiles of Backbone-Modified Glucagon-like Peptide-1 Analogues.

Authors:  Brian P Cary; Marlies V Hager; Samuel H Gellman
Journal:  Chembiochem       Date:  2019-09-20       Impact factor: 3.164

2.  Ligand-induced activation of ERK1/2 signaling by constitutively active Gs-coupled 5-HT receptors.

Authors:  Ping Liu; Yu-Ling Yin; Ting Wang; Li Hou; Xiao-Xi Wang; Man Wang; Guan-Guan Zhao; Yi Shi; H Eric Xu; Yi Jiang
Journal:  Acta Pharmacol Sin       Date:  2019-03-04       Impact factor: 6.150

Review 3.  GPCR Signaling and Trafficking: The Long and Short of It.

Authors:  Nathan J Pavlos; Peter A Friedman
Journal:  Trends Endocrinol Metab       Date:  2016-11-23       Impact factor: 12.015

4.  Stachel-independent modulation of GPR56/ADGRG1 signaling by synthetic ligands directed to its extracellular region.

Authors:  Gabriel S Salzman; Shu Zhang; Ankit Gupta; Akiko Koide; Shohei Koide; Demet Araç
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

5.  Activation of the GLP-1 receptor by a non-peptidic agonist.

Authors:  Peishen Zhao; Yi-Lynn Liang; Matthew J Belousoff; Giuseppe Deganutti; Madeleine M Fletcher; Francis S Willard; Michael G Bell; Michael E Christe; Kyle W Sloop; Asuka Inoue; Tin T Truong; Lachlan Clydesdale; Sebastian G B Furness; Arthur Christopoulos; Ming-Wei Wang; Laurence J Miller; Christopher A Reynolds; Radostin Danev; Patrick M Sexton; Denise Wootten
Journal:  Nature       Date:  2020-01-08       Impact factor: 49.962

6.  Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors.

Authors:  Yanting Yin; Parker W de Waal; Yuanzheng He; Li-Hua Zhao; Dehua Yang; Xiaoqing Cai; Yi Jiang; Karsten Melcher; Ming-Wei Wang; H Eric Xu
Journal:  J Biol Chem       Date:  2017-03-29       Impact factor: 5.157

7.  Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists.

Authors:  Sanaz Darbalaei; Ru-Lue Chang; Qing-Tong Zhou; Yan Chen; An-Tao Dai; Ming-Wei Wang; De-Hua Yang
Journal:  Acta Pharmacol Sin       Date:  2022-08-11       Impact factor: 7.169

8.  Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.

Authors:  Saifei Lei; Lachlan Clydesdale; Antao Dai; Xiaoqing Cai; Yang Feng; Dehua Yang; Yi-Lynn Liang; Cassandra Koole; Peishen Zhao; Thomas Coudrat; Arthur Christopoulos; Ming-Wei Wang; Denise Wootten; Patrick M Sexton
Journal:  J Biol Chem       Date:  2018-05-01       Impact factor: 5.157

9.  High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist.

Authors:  Janosch Ehrenmann; Jendrik Schöppe; Christoph Klenk; Mathieu Rappas; Lutz Kummer; Andrew S Doré; Andreas Plückthun
Journal:  Nat Struct Mol Biol       Date:  2018-11-19       Impact factor: 15.369

10.  Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor.

Authors:  Zhaotong Cong; Li-Nan Chen; Honglei Ma; Qingtong Zhou; Xinyu Zou; Chenyu Ye; Antao Dai; Qing Liu; Wei Huang; Xianqiang Sun; Xi Wang; Peiyu Xu; Lihua Zhao; Tian Xia; Wenge Zhong; Dehua Yang; H Eric Xu; Yan Zhang; Ming-Wei Wang
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.